Taken together, these data support the hypothesis that adipocyte Fam20c deletion enhances glucose metabolism and insulin sensitivity, providing a potential therapeutic avenue for improving metabolic function in established T2D. This evidence concerns the gene FAM20C and type 2 diabetes mellitus.